Protein and Peptide Substances in the Treatment of Respiratory Syncytial Infection: Current State

Respiratory syncytial virus infection (RSVI) is an acute medical and social problem in many countries globally. Infection is most dangerous for infants under one year old and the elderly. Despite its epidemiological relevance, only two drugs are registered for clinical use against RSVI: ribavirin (a...

Descripción completa

Detalles Bibliográficos
Autores principales: Shtro, Anna A., Petukhova, Galina D., Romanova, Aleksandra S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000545/
https://www.ncbi.nlm.nih.gov/pubmed/35408661
http://dx.doi.org/10.3390/molecules27072263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000545/
https://www.ncbi.nlm.nih.gov/pubmed/35408661
http://dx.doi.org/10.3390/molecules27072263

Ejemplares similares